| Tag | Content |
|---|
EnhancerAtlas ID | HS148-03308 |
Organism | Homo sapiens |
Tissue/cell | NHLF |
Coordinate | chr11:72545730-72547780 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Stat4 | MA0518.1 | chr11:72547385-72547399 | CCGCTTCCTGGAAG | - | 6.45 | | Zfx | MA0146.2 | chr11:72547036-72547050 | CCCGCCTCGGCCTC | + | 6.01 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09492 | chr11:72542547-72547834 | CD14 | | SE_10921 | chr11:72532771-72551542 | CD20 | | SE_13957 | chr11:72545852-72546900 | CD34_Primary_RO01536 | | SE_42971 | chr11:72544986-72547998 | Lung | | SE_53568 | chr11:72542520-72548110 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr11 | 72546015 | 72546343 | | chr11 | 72546001 | 72546450 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I072831 | chr11 | 72542121 | 72548050 |
|
Enhancer Sequence | AATTCTCCTG CCTCAGTCTC CCGAGTAGCT GGGATTACAG GTACCCACCA CCACACCTGG 60
CTAATTTTTG TATTTTTAGT AAGAGACGGG GTTTCCATTA TGTTGGTCAG GCTGGTCTCA 120
AACTCCTGAT CTCAGGTGAT CCACCAGCCT TGGCCTCCCA AAGTGCTGGG ATTACAGGCG 180
TAAGCCACCG TGCCCAGCCA TCATTCCATT CCTTTACAAT TGAGGATGTG GCAGCTAAGA 240
GGGAAAGGTC TTCCATCAAG CAGTGGCAGG GCTAAGGCCA GATGATGCCC TCCCACTGGG 300
TCTCTGGCTT GTGAATGTGG CTGGGGTGGT GGGTCAGAGA GGAAGGGGAT CTAGGTGGTG 360
TACTGAGAAC CTGTGGGTTG ATTGCATCAT GCATCAAGTC AGTTCCTGTG ATGAAGGAGA 420
CCAAAATTTA GCTATGACGC TGGGGTGAGG CAGTTAGCTG AGCTTTGCCC TTGGTCACAG 480
ACGGAACCTC CAGTACCGAA AGCAGCTTTC ACTGGCAGGG AAGTCAGAAG ACGGAAATGA 540
CATTTCGTGT CCTGACAGCC CTTCCCACAT TTTTGGTAGA GCACTTCACA CACATTCTTT 600
CCCTTGGGCC TTATGACAAC TCTGTGCGTT ACTATGGGCC TGGAAGACTA TCAAGGACCC 660
TAGTTCTGGA GGGAAGGACA CTGAGAAGAG GCAGGAGAGG TGGTGGTGAG AAAAGGCAGG 720
AGAGGTGGTG GTGAGGAGAG GTGGTGGTGA GGAGAGGTGG TGGTGAGAAG AGTTCGTGGT 780
GACCAGCCTG TGGCACACTT TATATGGCCT TCCTGGAACC ACAGTCTTAT TCTCAGGTTC 840
CAGATGAGGA CACAGGCTCA GTCCCCATGG CTGTCAAGTG GCAGAGCCAG GATTTAACCC 900
AGACCTCCTG GCTCCTAAGT CCATATGCGG TTGGTGGGAG TGTAAATGGA TATAGTCCTT 960
ATAGGAAGCC AATTTGGCAA AATCTAACAA AATTAAATAC ATACCTTTTT GACCCTCAAA 1020
TTCCACACTT AGGAATCTAC CCAACATTTA TACTGGAACA TATTTTTTTT TTTTTTTTTT 1080
GAGACAGAGT TTCACTCTTG TTCCCCAGAC TGGAGTGTAA TGGCACAATC TCAGCTCACC 1140
GCAACCTCTG CCTCGCAGGT TCAAGCGATT CTCCTGCCTC AGCCTCCAGA GTAACTGGGA 1200
TTACAGGCAT GAGCTACCAT GCCCAGCCAA TTTTGTATTT TCGGTAGAGA CTGGGTTTCT 1260
CCATGTTGGT CAGGCTGGTC TCAAACTCCT GACCTCAAGT GATCTGCCCG CCTCGGCCTC 1320
CCAAAGTGCT GGGATTACAG GCATGAGCCA CTGCGCCCGG CTGAACACAT TTTTATGTAA 1380
ACAAGCAGTG TGTACACTTA AGAGTCTTAT GCACAGGATA ATGTCTGGAA AAATGCTTAC 1440
TGCATGTCCC CAGCTCCAGG AAAGAGGAGA GCTTGTGGGG CCCTTCCCCA AACAGGCTGT 1500
GTCCTGGTCC TCAGTGTGGC TGGCTGGAAG CCAGGGGGAC TCAGCCTTTG ACTAAGAATG 1560
CTCCATCCAC CCCTGGGACC GAGAAAATCT CCTTTCACAC AATTCATTAC TCCTTAGGGT 1620
GGAGGTTTAG GAAAGGGGAG AGGCATCCAG AATGCCCGCT TCCTGGAAGC CAGTGGTCAC 1680
ATCCGGCAAG GGGACTTCAG TGACCTTCCT CTCACCCCTC CAGCAGCAGA ATCAGAGCTC 1740
CCTCCTCAGC TGCCTCTATG CTATCTGCCC CTCCCTTCTA GCACATGTCC CACAGTACTG 1800
TCCTCACGTA TTTCTTTTTT TTCCCATGGG AAAAGCAAAG ACCGTAACCT ATTTACTGCC 1860
ATCTCTAGTA CCCAGGATAT TACACCTAGC ACATGGGGGC TTCAGGGACT GTCTGTCTCA 1920
TAGATGGATT AATTTACTTT CTCCTCTCTC TGTCTGTTAG CTGGTTTAAA GGAGGGCCCA 1980
GGAATGTTTT TATAAGAAGC ATGGGCCTTT TGGAAAGGTC TGTTTACCCA AACCTTTCTA 2040
TATTAAAACT 2050
|
